法规动态

FDA、EMA、TGA 及全球法规动态

#Ranolazine ×

2026年9月3日•1 分钟阅读

FDA Approves ANDA209953 for Ranolazine Extended‑Release Tablets

The FDA has approved ANDA209953 for generic Ranolazine extended‑release tablets (500 mg and 1 g) manufactured by Ascend Laboratories and sponsored by ALKEM LABS.